-
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Strong evidence was found that slow gait speed, low physical activity, and weight loss are key indicators of frailty, which is associated with chronic disability, long-term nursing home stays, injurious falls, and death.
-
The syllogistic process that led us all to accept the utility of ASA in prevention of CVD in diabetics seemed innocent enough: a) ASA reduces CV events in persons with CVD, and b) diabetes is considered a CV risk equivalent; therefore, c) ASA must reduce CV events in persons with diabetes.
-
The American College of Physicians has just published a new clinical practice guideline on the use of second-generation antidepressants in treating depressive disorders.
-
The FDA has approved a new, highly selective alpha-1 adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia (BPH).
-
The relationship between uric acid (URA) and cardiovascular (CV) risk has been the subject of controversy for decades.
-
-
The presence of emphysema by CT scan or of airflow obstruction by spirometry predicts an increased risk of lung cancer.
-
This first known study of the effects of a 3-year cardiac rehabilitation program following a myocardial infarction (MI) included a continuous reinforced educational and behavioral intervention and proved effective in decreasing the risk of several important secondary cardiovascular (CV) outcomes.
